SAR 50.0
(2.46%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 11.02 Million SAR | 56.58% |
2022 | 7.03 Million SAR | 1827.97% |
2021 | -407.38 Thousand SAR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 1.55 Million SAR | -84.42% |
2024 Q2 | 1.55 Million SAR | 448.4% |
2023 Q3 | 1.85 Million SAR | -71.43% |
2023 FY | 11.02 Million SAR | 56.58% |
2023 Q1 | -2.59 Million SAR | -140.77% |
2023 Q2 | 6.5 Million SAR | 350.55% |
2023 Q4 | 9.99 Million SAR | 437.54% |
2022 Q4 | 6.36 Million SAR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Middle East Pharmaceutical Industries Co. | 44.67 Million SAR | 75.327% |
Al-Dawaa Medical Services Company | 2.23 Billion SAR | 99.508% |
Nahdi Medical Company | 265.09 Million SAR | 95.842% |
Almujtama Alraida Medical Co. | 155.88 Million SAR | 92.929% |